RYM · RYTHM, Inc. · Insider Trading

Reflects Pre-Funded Warrants issued as payment of interest pursuant to a Convertible Note of the Issuer dated May 25, 2025 and held by RSLGH, LLC ("RSLGH").

RSLGH is the direct beneficial owner of the May 25, 2025 Convertible Note and is the direct beneficial owner of the Pre-Funded Warrants. RSLGH is an indirectly, wholly-owned subsidiary of Green Thumb Industries Inc. ("Green Thumb"). Green Thumb is the sole shareholder of GTI23, Inc., which is the sole member of VCP23, LLC, which is the sole shareholder of For Success Holding Company. For Success Holding Company is the sole member of Wellness Mgmt, LLC, which is the sole member of RSLGH.

Reflects Pre-Funded Warrants issued as payment of interest pursuant to a Convertible Note of the Issuer dated August 25, 2025 and held by RSLGH, LLC ("RSLGH").

RSLGH is the direct beneficial owner of the August 25, 2025 Convertible Note and is the direct beneficial owner of the Pre-Funded Warrants. RSLGH is an indirectly, wholly-owned subsidiary of Green Thumb Industries Inc. ("Green Thumb"). Green Thumb is the sole shareholder of GTI23, Inc., which is the sole member of VCP23, LLC, which is the sole shareholder of For Success Holding Company. For Success Holding Company is the sole member of Wellness Mgmt, LLC, which is the sole member of RSLGH.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.07 to $26.96, inclusive. The reporting person hereby undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (3) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.03 to $27.41, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.05 to $26.81, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.76, inclusive. The reporting person hereby undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) to this Form 4.

Award granted in the form of restricted stock units under the issuer's 2022 Omnibus Equity Incentive Plan, as amended. 100% of the restricted stock units will vest on the earlier of (i) the one year anniversary of the date of the grant of the restricted stock units and (ii) the next annual meeting of the stockholders of the issuer following the date of the grant of the restricted stock units, subject to the reporting person's continuous service to the issuer through such vesting date.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.14 to $27.93, inclusive.

Award granted in the form of restricted stock units under the issuer's 2022 Omnibus Equity Incentive Plan, as amended. 100% of the restricted stock units will vest on the earlier of (i) the one year anniversary of the date of the grant of the restricted stock units and (ii) the next annual meeting of the stockholders of the issuer following the date of the grant of the restricted stock units, subject to the reporting person's continuous service to the issuer through such vesting date.

Award granted in the form of restricted stock units under the issuer's 2022 Omnibus Equity Incentive Plan, as amended. 100% of the restricted stock units will vest on the earlier of (i) the one year anniversary of the date of the grant of the restricted stock units and (ii) the next annual meeting of the stockholders of the issuer following the date of the grant of the restricted stock units, subject to the reporting person's continuous service to the issuer through such vesting date.

Award granted in the form of restricted stock units under the issuer's 2022 Omnibus Equity Incentive Plan, as amended. 100% of the restricted stock units will vest on the earlier of (i) the one year anniversary of the date of the grant of the restricted stock units and (ii) the next annual meeting of the stockholders of the issuer following the date of the grant of the restricted stock units, subject to the reporting person's continuous service to the issuer through such vesting date.

Award granted in the form of restricted stock units under the issuer's 2022 Omnibus Equity Incentive Plan, as amended. 100% of the restricted stock units will vest on the earlier of (i) the one year anniversary of the date of the grant of the restricted stock units and (ii) the next annual meeting of the stockholders of the issuer following the date of the grant of the restricted stock units, subject to the reporting person's continuous service to the issuer through such vesting date.

Award granted in the form of restricted stock units under the issuer's 2022 Omnibus Equity Incentive Plan, as amended. 100% of the restricted stock units will vest on the earlier of (i) the one year anniversary of the date of the grant of the restricted stock units and (ii) the next annual meeting of the stockholders of the issuer following the date of the grant of the restricted stock units, subject to the reporting person's continuous service to the issuer through such vesting date.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.87, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to 26.93, inclusive. The reporting person hereby undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (2) to this Form 4.

Shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units held by the reporting person.

Award granted in the form of restricted stock units under the issuer's 2022 Omnibus Equity Incentive Plan, as amended that vest in 50% increments on March 15, 2027 and June 15, 2028

The reported transaction involved the reporting person's receipt of a grant of 14,375 restricted stock units under the issuer's 2022 Omnibus Equity Incentive Plan, as amended (the "Plan") that vest in 50% increments on March 15, 2027 and June 15, 2028 subject to the reporting person's continued service through each applicable date. The reporting person has reported a prior award of restricted stock units in Table II of Form 4. The total reported in Column 5 includes the 14,375 newly awarded restricted stock units, 50,000 restricted stock units issued under the Plan previously reported in Table II, and 19,000 shares of common stock held directly by the reporting person.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.50, inclusive. The reporting person hereby undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.85, inclusive. The reporting person hereby undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.05, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.76, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to 20.95, inclusive. The reporting person hereby undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (3) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.50 to $25.16, inclusive.

Shares of the issuer's common stock were issued to the reporting person upon the settlement of restricted stock units on June 12, 2025.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the issuer.

The reporting person was granted 5,000 restricted stock units on November 19, 2024 under the Plan. All of the restricted stock units settled on June 12, 2025.

Shares of the issuer's common stock were issued to the reporting person upon the settlement of restricted stock units on June 12, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.50 to $23.41, inclusive. The reporting person hereby undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (7) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.625 to $25.70, inclusive.

Shares of the issuer's common stock were issued to the reporting person upon the settlement of restricted stock units on June 12, 2025.

Shares of the issuer's common stock were issued to the reporting person upon the settlement of restricted stock units on June 12, 2025.

Shares of the issuer's common stock were issued to the reporting person upon the settlement of restricted stock units on June 12, 2025.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the issuer.

The reporting person was granted 5,000 restricted stock units on November 19, 2024 under the Plan. All of the restricted stock units settled on June 12, 2025.

Shares of the issuer's common stock were issued to the reporting person upon the settlement of restricted stock units on June 12, 2025.

Shares of the issuer's common stock were issued to the reporting person upon the settlement of restricted stock units on June 12, 2025.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the issuer.

The reporting person was granted 5,000 restricted stock units on November 19, 2024 under the Plan. All of the restricted stock units settled on June 12, 2025.

Shares of the issuer's common stock were issued to the reporting person upon the settlement of restricted stock units on June 12, 2025.

Shares of the issuer's common stock were issued to the reporting person upon the settlement of restricted stock units on June 12, 2025.

Shares of the issuer's common stock were issued to the reporting person upon the settlement of restricted stock units on June 12, 2025.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the issuer.

The reporting person was granted 1,250 restricted stock units on January 31, 2025 under the Plan. All of the restricted stock units settled on June 12, 2025.

Shares of the issuer's common stock were issued to the reporting person upon the settlement of restricted stock units on June 12, 2025.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the issuer.

The reporting person was granted 5,000 restricted stock units on November 19, 2024 under the Plan. All of the restricted stock units settled on June 12, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.50 to $24.40, inclusive.

Shares of the issuer's common stock were issued to the reporting person upon the settlement of restricted stock units on June 12, 2025.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the issuer.

The reporting person was granted 1,250 restricted stock units on January 31, 2025 under the Plan. All of the restricted stock units settled on June 12, 2025.